IRIS
LASAGNA, ANGIOLETTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 443
EU - Europa 280
AS - Asia 83
SA - Sud America 5
AF - Africa 2
OC - Oceania 1
Totale 814
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 442
IT - Italia 100
IE - Irlanda 97
CN - Cina 44
FI - Finlandia 37
SG - Singapore 25
DE - Germania 21
AT - Austria 6
IN - India 4
AR - Argentina 3
FR - Francia 3
HR - Croazia 3
BE - Belgio 2
HK - Hong Kong 2
MA - Marocco 2
NL - Olanda 2
PE - Perù 2
TR - Turchia 2
AU - Australia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
GB - Regno Unito 1
GE - Georgia 1
IL - Israele 1
JM - Giamaica 1
JP - Giappone 1
LK - Sri Lanka 1
LU - Lussemburgo 1
PT - Portogallo 1
RO - Romania 1
RU - Federazione Russa 1
UA - Ucraina 1
VN - Vietnam 1
Totale 814
Salva come PNG Salva come JPEG
Città #
Chandler 97
Dublin 93
New York 48
Boardman 45
Ashburn 41
Helsinki 37
Shanghai 28
Seattle 18
Singapore 17
Princeton 14
Lawrence 13
Milan 13
Medford 12
Rome 12
Beijing 9
Munich 6
Vienna 6
Wilmington 6
Guangzhou 5
Los Angeles 5
Pavia 4
Bergamo 3
Buenos Aires 3
Desio 3
Pescara 3
Reggio Emilia 3
Washington 3
Alghero 2
Ann Arbor 2
Biassono 2
Bolu 2
Chicago 2
Dallas 2
Jette 2
Lima 2
Livorno 2
Monza 2
Muggiò 2
Norwalk 2
Ospitaletto 2
Pune 2
Ravenna 2
Serrone 2
Tangier 2
Turin 2
Amsterdam 1
Attalens 1
Baku 1
Borca 1
Brno 1
Brugherio 1
Central 1
Clarks Summit 1
Colombo 1
Crotone 1
Frankfurt am Main 1
Gunzenhausen 1
Gurgaon 1
Haifa 1
Hangzhou 1
Jinan 1
Latina 1
Lisbon 1
Lodi 1
Luxembourg 1
Melbourne 1
Nagold 1
Piscataway 1
Redwood City 1
Rovello Porro 1
San Diego 1
San Francisco 1
Tbilisi 1
Tokyo 1
Valsamoggia 1
Woodbridge 1
Zagreb 1
Totale 615
Salva come PNG Salva come JPEG
Nome #
Risk of reactivation of occult hepatitis B during immunotherapy in cancer treatment: myth, reality or new horizons? 46
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 44
Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center 41
The institution of a Multi-disciplinary Italian Breast Unit: Reflections of the first psychosocial research study results on distress and quality of life 39
Torque teno virus and cancers: current knowledge 37
How to use prophylactic G-CSF in the time of COVID-19 37
Reply to Y. Ergun et al 36
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research 35
Immunogenicity and safety after the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors on active treatment: a prospective cohort study 35
Vickers micro-hardness of new restorative CAD/CAM dental materials: Evaluation and comparison after exposure to acidic drink 34
Positive predictive value for malignancy of uncertain malignant potential (B3) breast lesions diagnosed on vacuum-assisted biopsy (VAB): is surgical excision still recommended? 34
G-CSF and G-CSF-related vasculitis: A systematic review of the literature and intriguing future research perspectives 34
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 34
Herpes zoster in patients with solid tumors treated with immune checkpoint inhibitors 34
A snapshot of the immunogenicity, efficacy and safety of a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors: a longitudinal cohort study 29
Randomized trial of sucrosomial iron supplementation in patients with chemotherapy-related anemia treated with ESA 25
Humoral and cellular response before and after the fourth BNT162b2 vaccine dose in patients with solid tumors on active treatment 19
Analysis of the humoral and cellular immune response after a full course of BNT162b2 anti-SARS-CoV-2 vaccine in cancer patients treated with PD-1/PD-L1 inhibitors with or without chemotherapy: an update after 6 months of follow-up 19
Case report: Successful outcome of COVID-19 in the context of autologous hematopoietic stem cell transplantation: The impact of the anti-SARS-CoV-2 vaccine and early remdesivir 19
The Bio-Diversity and the Role of Gut Microbiota in Postmenopausal Women with Luminal Breast Cancer Treated with Aromatase Inhibitors: An Observational Cohort Study 19
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study 18
A 1-year follow-up study on checkpoint inhibitor-induced colitis: results from a European consortium 18
The immunogenicity and the safety of the adjuvanted glycoprotein E (gE)-based recombinant vaccine against herpes zoster (RZV) in cancer patients during immunotherapy 18
Occult hepatitis B in patients with cancer during immunotherapy with or without chemotherapy: A real-life retrospective single-center cohort study 17
The 'hit-and-run' strategy and viral carcinogenesis 16
Effectiveness of the available early therapies in reducing severe COVID-19 in non-hospitalized patients with solid tumors on active treatment 15
Persistence of Immune Response Elicited by Three Doses of mRNA Vaccine against SARS-CoV-2 in a Cohort of Patients with Solid Tumors: A One-Year Follow-Up 15
COVID-19 and breast cancer: May the microbiome be the issue? 15
Long-COVID in Patients with Cancer Previously Treated with Early Anti-SARS-CoV-2 Therapies in an Out-of-Hospital Setting: A Single-Center Experience 14
Infectious complications and immunotherapy: old pitfalls and new horizons 14
Six-month humoral and cellular immune response to the third dose of BNT162b2 anti-SARS-CoV-2 vaccine in patients with solid tumors: a longitudinal cohort study with a focus on the variants of concern 12
Concordance of immunohistochemistry for predictive and prognostic factors in breast cancer between biopsy and surgical excision: a single-centre experience and review of the literature 9
The Role of Oncogenic Viruses in the Pathogenesis of Sporadic Breast Cancer: A Comprehensive Review of the Current Literature 9
Vaccination for seasonal influenza, pneumococcal infection and SARS-CoV-2 in patients with solid tumors: recommendations of the Associazione Italiana di Oncologia Medica (AIOM) 8
Treatment beyond progression and locoregional approaches in selected patients with BRAF-mutated metastatic melanoma 7
Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM) 4
Impact of proton pump inhibitors on the onset of gastrointestinal immune‐related adverse events during immunotherapy 4
Unlocking the Potential: Epstein-Barr Virus (EBV) in Gastric Cancer and Future Treatment Prospects, a Literature Review 1
Totale 864
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208 0 0 0 0 0 0 2 0 0 0 6 0
2020/20216 0 0 0 0 0 1 3 1 0 0 0 1
2021/202284 6 0 1 0 4 1 10 5 2 11 7 37
2022/2023285 22 29 4 26 21 13 0 10 114 2 40 4
2023/2024350 41 51 14 22 29 85 24 31 0 11 14 28
2024/2025130 26 40 45 9 10 0 0 0 0 0 0 0
Totale 864